Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niels Kruse

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Journal of Immunological Methods|August 15, 2015
Validation of a commercially available enzyme-linked immunoabsorbent assay for the quantification of human α-Synuclein in cerebrospinal fluidNiels Kruse, Brit Mollenhauer
Methods in Molecular Biology (Clifton, N.J.)|February 17, 2019
Quantification of Alpha-Synuclein in Biological Fluids by Electrochemiluminescence-Based DetectionNiels Kruse, Brit Mollenhauer
Journal of Neuroimmunology|November 30, 2002
CTLA4 exon 1 dimorphism is associated with primary progressive multiple sclerosisMathias Mäurer, Anke Ponath, Niels Kruse, et al.
Bioanalysis|May 16, 2017
Validation of electrochemiluminescence assays for highly sensitive and reproducible quantification of α-synuclein in cerebrospinal fluidNiels Kruse, Omar M El-Agnaf, Brit Mollenhauer
Journal of Neuroimmunology|October 19, 2006
Differential expression of BDNF mRNA splice variants in mouse brain and immune cellsNiels Kruse, Seray Cetin, Andrew Chan, et al.
Neuropathology and Applied Neurobiology|February 3, 2015
Natalizumab analogon therapy is effective in a B cell-dependent multiple sclerosis modelDarius Häusler, Stefan Nessler, Niels Kruse, et al.
Methods (San Diego, Calif.)|April 3, 2012
Development of electrochemiluminescence-based singleplex and multiplex assays for the quantification of α-synuclein and other proteins in cerebrospinal fluidNiels Kruse, Walter J Schulz-Schaeffer, Michael G Schlossmacher, et al.
BMC Medical Genetics|December 10, 2008
Genomic NGFB variation and multiple sclerosis in a case control studyDenis A Akkad, Niels Kruse, Larissa Arning, et al.
Journal of Neurology|November 14, 2022
Neurofilament light chains in serum as biomarkers of axonal damage in early MS lesions: a histological-serological correlative studyAnne-Sophie Dietmann, Niels Kruse, Lidia Stork, et al.
Cells|February 9, 2020
Blood Contamination in CSF and Its Impact on Quantitative Analysis of Alpha-SynucleinKatalin Barkovits, Niels Kruse, Andreas Linden, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Journal of Immunological Methods|August 15, 2015
Validation of a commercially available enzyme-linked immunoabsorbent assay for the quantification of human α-Synuclein in cerebrospinal fluidNiels Kruse, Brit Mollenhauer
Methods in Molecular Biology (Clifton, N.J.)|February 17, 2019
Quantification of Alpha-Synuclein in Biological Fluids by Electrochemiluminescence-Based DetectionNiels Kruse, Brit Mollenhauer
Journal of Neuroimmunology|November 30, 2002
CTLA4 exon 1 dimorphism is associated with primary progressive multiple sclerosisMathias Mäurer, Anke Ponath, Niels Kruse, et al.
Bioanalysis|May 16, 2017
Validation of electrochemiluminescence assays for highly sensitive and reproducible quantification of α-synuclein in cerebrospinal fluidNiels Kruse, Omar M El-Agnaf, Brit Mollenhauer
Journal of Neuroimmunology|October 19, 2006
Differential expression of BDNF mRNA splice variants in mouse brain and immune cellsNiels Kruse, Seray Cetin, Andrew Chan, et al.
Neuropathology and Applied Neurobiology|February 3, 2015
Natalizumab analogon therapy is effective in a B cell-dependent multiple sclerosis modelDarius Häusler, Stefan Nessler, Niels Kruse, et al.
Methods (San Diego, Calif.)|April 3, 2012
Development of electrochemiluminescence-based singleplex and multiplex assays for the quantification of α-synuclein and other proteins in cerebrospinal fluidNiels Kruse, Walter J Schulz-Schaeffer, Michael G Schlossmacher, et al.
BMC Medical Genetics|December 10, 2008
Genomic NGFB variation and multiple sclerosis in a case control studyDenis A Akkad, Niels Kruse, Larissa Arning, et al.
Journal of Neurology|November 14, 2022
Neurofilament light chains in serum as biomarkers of axonal damage in early MS lesions: a histological-serological correlative studyAnne-Sophie Dietmann, Niels Kruse, Lidia Stork, et al.
Cells|February 9, 2020
Blood Contamination in CSF and Its Impact on Quantitative Analysis of Alpha-SynucleinKatalin Barkovits, Niels Kruse, Andreas Linden, et al.
Pageof 5